Characterization of Nrf1b, a Novel Isoform of the Nuclear Factor-Erythroid-2 Related Transcription Factor-1 That Activates Antioxidant Response Element-Regulated Genes

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Kwong, Eric K ^a   Kim, Kyung Mi ^a   Penalosa, Patrick J ^a   Chan, Jefferson Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; LUCIFERASE; TRANSCRIPTION FACTOR GAL4; TRANSCRIPTION FACTOR MAFG; TRANSCRIPTION FACTOR NRF1; TRANSCRIPTION FACTOR NRF1A; TRANSCRIPTION FACTOR NRF1B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CELL FRACTIONATION; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DNA FLANKING REGION; ENDOPLASMIC RETICULUM; EXON; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

5' FLANKING REGION; ALTERNATIVE SPLICING; ANIMALS; ANTIOXIDANT RESPONSE ELEMENTS; BLOTTING, WESTERN; CELL NUCLEUS; COS CELLS; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; LUCIFERASES; MAFG TRANSCRIPTION FACTOR; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; NUCLEAR RESPIRATORY FACTOR 1; PROTEIN BINDING; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84868110723     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048404     Document Type: Article

References (37)

1. Andrews NC, Erdjument-Bromage H, Davidson MB, Tempst P, Orkin SH, (1993) Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein. Nature 362: 722-728.
2. Chan JY, Han XL, Kan YW, (1993) Cloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast. Proc Natl Acad Sci U S A 90: 11371-11375.
3. Kobayashi A, Ito E, Toki T, Kogame K, Takahashi S, et al. (1999) Molecular cloning and functional characterization of a new Cap'n' collar family transcription factor Nrf3. J Biol Chem 274: 6443-6452.
4. Moi P, Chan K, Asunis I, Cao A, Kan YW, (1994) Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci U S A 91: 9926-9930.
5. Motohashi H, O'Connor T, Katsuoka F, Engel JD, Yamamoto M, (2002) Integration and diversity of the regulatory network composed of Maf and CNC families of transcription factors. Gene 294: 1-12.
6. Chan JY, Kwong M, Lu R, Chang J, Wang B, et al. (1998) Targeted disruption of the ubiquitous CNC-bZIP transcription factor, Nrf-1, results in anemia and embryonic lethality in mice. Embo J 17: 1779-1787.
7. Johnsen O, Murphy P, Prydz H, Kolsto AB, (1998) Interaction of the CNC-bZIP factor TCF11/LCR-F1/Nrf1 with MafG: binding-site selection and regulation of transcription. Nucleic Acids Res 26: 512-520.
8. Nguyen T, Sherratt PJ, Pickett CB, (2003) Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annual review of pharmacology and toxicology 43: 233-260.
9. Kwak MK, Wakabayashi N, Greenlaw JL, Yamamoto M, Kensler TW, (2003) Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway. Molecular and cellular biology 23: 8786-8794.
10. Kensler TW, Wakabayashi N, Biswal S, (2007) Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annual review of pharmacology and toxicology 47: 89-116.
11. Li J, Lee JM, Johnson JA, (2002) Microarray analysis reveals an antioxidant responsive element-driven gene set involved in conferring protection from an oxidative stress-induced apoptosis in IMR-32 cells. The Journal of biological chemistry 277: 388-394.
12. Xu Z, Chen L, Leung L, Yen TS, Lee C, et al. (2005) Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia. Proc Natl Acad Sci U S A 102: 4120-4125.
13. Lee CS, Lee C, Hu T, Nguyen JM, Zhang J, et al. (2011) Loss of nuclear factor E2-related factor 1 in the brain leads to dysregulation of proteasome gene expression and neurodegeneration. Proceedings of the National Academy of Sciences of the United States of America 108: 8408-8413.
14. Ohtsuji M, Katsuoka F, Kobayashi A, Aburatani H, Hayes JD, et al. (2008) Nrf1 and Nrf2 play distinct roles in activation of antioxidant response element-dependent genes. J Biol Chem 283: 33554-33562.
15. Radhakrishnan SK, Lee CS, Young P, Beskow A, Chan JY, et al. (2010) Transcription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cells. Mol Cell 38: 17-28.
16. Xing W, Singgih A, Kapoor A, Alarcon CM, Baylink DJ, et al. (2007) Nuclear factor-E2-related factor-1 mediates ascorbic acid induction of osterix expression via interaction with antioxidant-responsive element in bone cells. J Biol Chem 282: 22052-22061.
17. Berg DT, Gupta A, Richardson MA, O'Brien LA, Calnek D, et al. (2007) Negative regulation of inducible nitric-oxide synthase expression mediated through transforming growth factor-beta-dependent modulation of transcription factor TCF11. J Biol Chem 282: 36837-36844.
18. Narayanan K, Ramachandran A, Peterson MC, Hao J, Kolsto AB, et al. (2004) The CCAAT enhancer-binding protein (C/EBP)beta and Nrf1 interact to regulate dentin sialophosphoprotein (DSPP) gene expression during odontoblast differentiation. J Biol Chem 279: 45423-45432.
19. Husberg C, Murphy P, Bjorgo E, Kalland KH, Kolsto AB, (2003) Cellular localisation and nuclear export of the human bZIP transcription factor TCF11. Biochimica et biophysica acta 1640: 143-151.
20. Husberg C, Murphy P, Martin E, Kolsto AB, (2001) Two domains of the human bZIP transcription factor TCF11 are necessary for transactivation. J Biol Chem 276: 17641-17652.
21. Wang W, Kwok AM, Chan JY, (2007) The p65 isoform of Nrf1 is a dominant negative inhibitor of ARE-mediated transcription. J Biol Chem 282: 24670-24678.
22. Wang W, Chan JY, (2006) Nrf1 is targeted to the endoplasmic reticulum membrane by an N-terminal transmembrane domain. Inhibition of nuclear translocation and transacting function. J Biol Chem 281: 19676-19687.
23. Zhang Y, Crouch DH, Yamamoto M, Hayes JD, (2006) Negative regulation of the Nrf1 transcription factor by its N-terminal domain is independent of Keap1: Nrf1, but not Nrf2, is targeted to the endoplasmic reticulum. Biochem J 399: 373-385.
24. Steffen J, Seeger M, Koch A, Kruger E, (2010) Proteasomal degradation is transcriptionally controlled by TCF11 via an ERAD-dependent feedback loop. Mol Cell 40: 147-158.
25. Zhang Y, Lucocq JM, Yamamoto M, Hayes JD, (2007) The NHB1 (N-terminal homology box 1) sequence in transcription factor Nrf1 is required to anchor it to the endoplasmic reticulum and also to enable its asparagine-glycosylation. Biochem J 408: 161-172.
26. Zhao R, Hou Y, Xue P, Woods CG, Fu J, et al. (2011) Long isoforms of NRF1 contribute to arsenic-induced antioxidant response in human keratinocytes. Environ Health Perspect 119: 56-62.
27. Biswas M, Phan D, Watanabe M, Chan JY, (2011) The Fbw7 tumor suppressor regulates nuclear factor E2-related factor 1 transcription factor turnover through proteasome-mediated proteolysis. The Journal of biological chemistry 286: 39282-39289.
28. Tsuchiya Y, Morita T, Kim M, Iemura S, Natsume T, et al. (2011) Dual regulation of the transcriptional activity of Nrf1 by beta-TrCP- and Hrd1-dependent degradation mechanisms. Molecular and cellular biology 31: 4500-4512.
29. Mironov AA, Fickett JW, Gelfand MS, (1999) Frequent alternative splicing of human genes. Genome research 9: 1288-1293.
30. Ayoubi TA, Van De Ven WJ, (1996) Regulation of gene expression by alternative promoters. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 10: 453-460.
31. Baek D, Davis C, Ewing B, Gordon D, Green P, (2007) Characterization and predictive discovery of evolutionarily conserved mammalian alternative promoters. Genome research 17: 145-155.
32. Gascard P, Parra MK, Zhao Z, Calinisan VR, Nunomura W, et al. (2004) Putative tumor suppressor protein 4.1B is differentially expressed in kidney and brain via alternative promoters and 5′ alternative splicing. Biochimica et biophysica acta 1680: 71-82.
33. Cianetti L, Di Cristofaro A, Zappavigna V, Bottero L, Boccoli G, et al. (1990) Molecular mechanisms underlying the expression of the human HOX-5.1 gene. Nucleic acids research 18: 4361-4368.
34. Azizkhan JC, Jensen DE, Pierce AJ, Wade M, (1993) Transcription from TATA-less promoters: dihydrofolate reductase as a model. Critical reviews in eukaryotic gene expression 3: 229-254.
35. Kwak MK, Itoh K, Yamamoto M, Kensler TW, (2002) Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the nrf2 promoter. Molecular and cellular biology 22: 2883-2892.
36. Sandelin A, Carninci P, Lenhard B, Ponjavic J, Hayashizaki Y, et al. (2007) Mammalian RNA polymerase II core promoters: insights from genome-wide studies. Nature reviews Genetics 8: 424-436.
37. Mulac-Jericevic B, Conneely OM, (2004) Reproductive tissue selective actions of progesterone receptors. Reproduction 128: 139-146.